Literature DB >> 20112107

Th17 cytokines and vaccine-induced immunity.

Yinyao Lin1, Samantha R Slight, Shabaana A Khader.   

Abstract

T helper type 17 (Th17) cells are a distinct lineage of T cells that produce the effector molecules IL-17, IL-17F, IL-21, and IL-22. Although the role of Th17 cells in primary immune responses against infections is well documented, there is growing evidence that the Th17 lineage maybe critical for vaccine-induced memory immune responses against infectious diseases. Here, we summarize recent progress in our understanding of the role of IL-17 in vaccine-induced immunity.

Entities:  

Mesh:

Year:  2010        PMID: 20112107      PMCID: PMC2855296          DOI: 10.1007/s00281-009-0191-2

Source DB:  PubMed          Journal:  Semin Immunopathol        ISSN: 1863-2297            Impact factor:   9.623


  112 in total

1.  The use of Th1 cytokines, IL-12 and IL-23, to modulate the immune response raised to a DNA vaccine delivered by gene gun.

Authors:  Jonathan Williman; Euan Lockhart; Lynn Slobbe; Glenn Buchan; Margaret Baird
Journal:  Vaccine       Date:  2005-08-19       Impact factor: 3.641

2.  Expression and regulation of IL-22 in the IL-17-producing CD4+ T lymphocytes.

Authors:  Yeonseok Chung; Xuexian Yang; Seon Hee Chang; Li Ma; Qiang Tian; Chen Dong
Journal:  Cell Res       Date:  2006-11       Impact factor: 25.617

3.  TLR4 mediates vaccine-induced protective cellular immunity to Bordetella pertussis: role of IL-17-producing T cells.

Authors:  Sarah C Higgins; Andrew G Jarnicki; Ed C Lavelle; Kingston H G Mills
Journal:  J Immunol       Date:  2006-12-01       Impact factor: 5.422

4.  Changes in immune-related gene expression and intestinal lymphocyte subpopulations following Eimeria maxima infection of chickens.

Authors:  Yeong Ho Hong; Hyun S Lillehoj; Erik P Lillehoj; Sung Hyen Lee
Journal:  Vet Immunol Immunopathol       Date:  2006-10-12       Impact factor: 2.046

5.  Safety, efficacy, and immunogenicity of 2 doses of bovine-human (UK) and rhesus-rhesus-human rotavirus reassortant tetravalent vaccines in Finnish children.

Authors:  Timo Vesikari; Aino V Karvonen; Jukka Majuri; Shang-Qin Zeng; Xiao-Li Pang; Robert Kohberger; Bruce D Forrest; Yasutaka Hoshino; Robert M Chanock; Albert Z Kapikian
Journal:  J Infect Dis       Date:  2006-06-23       Impact factor: 5.226

6.  The orphan nuclear receptor RORgammat directs the differentiation program of proinflammatory IL-17+ T helper cells.

Authors:  Ivaylo I Ivanov; Brent S McKenzie; Liang Zhou; Carlos E Tadokoro; Alice Lepelley; Juan J Lafaille; Daniel J Cua; Dan R Littman
Journal:  Cell       Date:  2006-09-22       Impact factor: 41.582

7.  Interleukin 27 negatively regulates the development of interleukin 17-producing T helper cells during chronic inflammation of the central nervous system.

Authors:  Jason S Stumhofer; Arian Laurence; Emma H Wilson; Elaine Huang; Cristina M Tato; Leanne M Johnson; Alejandro V Villarino; Qiulong Huang; Akihiko Yoshimura; David Sehy; Christiaan J M Saris; John J O'Shea; Lothar Hennighausen; Matthias Ernst; Christopher A Hunter
Journal:  Nat Immunol       Date:  2006-08-13       Impact factor: 25.606

8.  Interleukin 27 limits autoimmune encephalomyelitis by suppressing the development of interleukin 17-producing T cells.

Authors:  Marcel Batten; Ji Li; Sothy Yi; Noelyn M Kljavin; Dimitry M Danilenko; Sophie Lucas; James Lee; Frederic J de Sauvage; Nico Ghilardi
Journal:  Nat Immunol       Date:  2006-08-13       Impact factor: 25.606

9.  Mice develop effective but delayed protective immune responses when immunized as neonates either intranasally with nonliving VP6/LT(R192G) or orally with live rhesus rotavirus vaccine candidates.

Authors:  John L VanCott; Anne E Prada; Monica M McNeal; Susan C Stone; Mitali Basu; Bert Huffer; Kristi L Smiley; Mingyuan Shao; Judy A Bean; John D Clements; Anthony H-C Choi; Richard L Ward
Journal:  J Virol       Date:  2006-05       Impact factor: 5.103

10.  Interleukin (IL)-22 and IL-17 are coexpressed by Th17 cells and cooperatively enhance expression of antimicrobial peptides.

Authors:  Spencer C Liang; Xiang-Yang Tan; Deborah P Luxenberg; Riyez Karim; Kyriaki Dunussi-Joannopoulos; Mary Collins; Lynette A Fouser
Journal:  J Exp Med       Date:  2006-09-18       Impact factor: 14.307

View more
  48 in total

Review 1.  Liposomes as vaccine delivery systems: a review of the recent advances.

Authors:  Reto A Schwendener
Journal:  Ther Adv Vaccines       Date:  2014-11

2.  Vaccines displaying mycobacterial proteins on biopolyester beads stimulate cellular immunity and induce protection against tuberculosis.

Authors:  Natalie A Parlane; Katrin Grage; Jun Mifune; Randall J Basaraba; D Neil Wedlock; Bernd H A Rehm; Bryce M Buddle
Journal:  Clin Vaccine Immunol       Date:  2011-11-09

Review 3.  Mechanisms of Cholera Toxin in the Modulation of TH17 Responses.

Authors:  Hsing-Chuan Tsai; Reen Wu
Journal:  Crit Rev Immunol       Date:  2015       Impact factor: 2.214

4.  Live Attenuated Leishmania donovani Centrin Gene-Deleted Parasites Induce IL-23-Dependent IL-17-Protective Immune Response against Visceral Leishmaniasis in a Murine Model.

Authors:  Antara Banerjee; Parna Bhattacharya; Pradeep K Dagur; Subir Karmakar; Nevien Ismail; Amritanshu B Joshi; Adovi D Akue; Mark KuKuruga; John Philip McCoy; Ranadhir Dey; Hira L Nakhasi
Journal:  J Immunol       Date:  2017-11-29       Impact factor: 5.422

5.  Safety, immunogenicity, and antibody persistence following an investigational Streptococcus pneumoniae and Haemophilus influenzae triple-protein vaccine in a phase 1 randomized controlled study in healthy adults.

Authors:  Johan Berglund; Peter Vink; Fernanda Tavares Da Silva; Pascal Lestrate; Dominique Boutriau
Journal:  Clin Vaccine Immunol       Date:  2013-10-30

Review 6.  Recent progress in mucosal vaccine development: potential and limitations.

Authors:  Nils Lycke
Journal:  Nat Rev Immunol       Date:  2012-07-25       Impact factor: 53.106

7.  Production of a particulate hepatitis C vaccine candidate by an engineered Lactococcus lactis strain.

Authors:  Natalie A Parlane; Katrin Grage; Jason W Lee; Bryce M Buddle; Michel Denis; Bernd H A Rehm
Journal:  Appl Environ Microbiol       Date:  2011-10-07       Impact factor: 4.792

8.  NDV-3, a recombinant alum-adjuvanted vaccine for Candida and Staphylococcus aureus, is safe and immunogenic in healthy adults.

Authors:  Clint S Schmidt; C Jo White; Ashraf S Ibrahim; Scott G Filler; Yue Fu; Michael R Yeaman; John E Edwards; John P Hennessey
Journal:  Vaccine       Date:  2012-10-22       Impact factor: 3.641

9.  A multi-epitope vaccine CTB-UE relieves Helicobacter pylori-induced gastric inflammatory reaction via up-regulating microRNA-155 to inhibit Th17 response in C57/BL6 mice model.

Authors:  Xiaobo Lv; Hui Song; Jue Yang; Tong Li; Tao Xi; Yingying Xing
Journal:  Hum Vaccin Immunother       Date:  2014       Impact factor: 3.452

Review 10.  The genetic basis for interindividual immune response variation to measles vaccine: new understanding and new vaccine approaches.

Authors:  Iana H Haralambieva; Inna G Ovsyannikova; V Shane Pankratz; Richard B Kennedy; Robert M Jacobson; Gregory A Poland
Journal:  Expert Rev Vaccines       Date:  2013-01       Impact factor: 5.217

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.